Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.
A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...
KMOV St. Louis on MSN9d
Nasal COVID vaccine developed at WashU approved for clinical trialsThe Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...
Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...
Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant depression. This marks a significant advancement in depression treatment ...
Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
The US Food and Drug Administration (FDA) has approved the use of esketamine nasal spray as a standalone treatment for adults with major depressive disorder (MDD) who have not responded adequately ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback